Charcot-Marie-Tooth Disease Recessive Intermediate D

Charcot-Marie-Tooth disease recessive intermediate D (often shortened to CMTRID) is a very rare inherited disease that damages the peripheral nerves, which are the long nerves that carry signals between the brain, spinal cord, feet, and hands. It is called “intermediate” because nerve tests show changes that are between a mainly demyelinating neuropathy and a mainly axonal neuropathy. In most families, the disease is caused by harmful changes (mutations) in a gene called COX6A1, which helps mitochondria make energy. Wikipedia+3MalaCards+3EMBL-EBI+3

In CMTRID, symptoms usually begin in childhood with unsteady walking, high-arched feet, and frequent falls, and then slowly progress over many years. Both movement (motor) and feeling (sensory) nerves are affected, so people may have weakness, muscle wasting, numbness, and reduced reflexes in the feet and hands. Some people can also develop hearing problems and nerve-related pain. NCBI+3Genetic Diseases Info Center+3NCBI+3

Other Names

“Charcot-Marie-Tooth disease recessive intermediate D” has several other names used in medical books and databases. All of them point to the same underlying condition. MalaCards+2EMBL-EBI+2

1. Autosomal recessive intermediate Charcot-Marie-Tooth disease type D
   This is the most descriptive name. “Autosomal recessive” explains the way the disease is inherited, “intermediate” describes the nerve test pattern, and “type D” tells doctors it is the subtype linked mainly to the COX6A1 gene. EMBL-EBI+1

2. CMTRID
   This is a short form built from the first letters of the longer name: Charcot-Marie-Tooth (CMT), recessive intermediate (RI), type D (D). It is often used in research papers and genetic reports. Monarch Initiative+1

3. RI-CMT type D
   Here “RI” means recessive intermediate. This label reminds clinicians that nerve conduction speeds in this disease are between the typical ranges seen in CMT1 (demyelinating) and CMT2 (axonal) forms. MalaCards+1

4. Charcot-Marie-Tooth disease caused by mutation in COX6A1
   This name focuses on the main gene that is affected. It tells geneticists that the problem lies in a mitochondrial protein (cytochrome c oxidase subunit 6A1) that is part of the electron transport chain. MalaCards+2UniProt+2

5. Hereditary motor and sensory neuropathy due to COX6A1 mutation
   “Hereditary motor and sensory neuropathy” is another way to describe CMT. Adding “due to COX6A1 mutation” clearly links the nerve damage to a specific genetic defect rather than to diabetes, toxins, or other acquired causes. MalaCards+2NCBI+2

Types of Charcot-Marie-Tooth Disease and Where CMTRID Fits

Charcot-Marie-Tooth disease is not a single condition but a large group of inherited neuropathies caused by changes in many different genes. Doctors divide CMT into major types based on nerve conduction studies, pattern of inheritance, and the main gene involved. NCBI+2NCBI+2

• CMT1 (demyelinating CMT) – Nerve conduction is slow because the myelin coating around nerve fibers is damaged.

• CMT2 (axonal CMT) – The nerve axon itself is mainly damaged, and conduction speeds are nearer normal but responses are low.

• CMT4 (autosomal recessive demyelinating CMT) – A recessive group with severe, early-onset demyelinating neuropathy.

• CMTX (X-linked CMT) – The faulty gene is on the X chromosome, often involving the GJB1 gene.

• Intermediate CMT (CMTRI) – Nerve conduction velocities are in an intermediate range, usually about 25–45 m/s in the median motor nerve. MalaCards+2UniProt+2

Within the “intermediate CMT” group, there are several autosomal recessive forms: CMTRIA, CMTRIB, CMTRIC, and CMTRID. CMTRID is specifically linked to harmful variants in COX6A1, while CMTRIC is linked to PLEKHG5, and the other types involve different genes. This genetic naming system helps doctors order the right gene tests and give accurate counseling for families. Charcot-Marie-Tooth Association+2MalaCards+2

Causes

Because CMTRID is a very rare genetic disease, doctors know one main cause: mutations in the COX6A1 gene. The 20 “causes” below describe this core cause, the different mutation patterns, and biological mechanisms or influences that help explain why the disease appears and how it behaves. UniProt+3MalaCards+3Monarch Initiative+3

1. COX6A1 gene mutation
   The primary cause of CMTRID is a disease-causing mutation in the COX6A1 gene. This gene encodes a small protein within cytochrome c oxidase (complex IV) in mitochondria. When the gene is faulty, the protein is abnormal or missing, which disrupts the final step of the mitochondrial respiratory chain. Wikipedia+2UniProt+2

2. Autosomal recessive inheritance
   CMTRID follows an autosomal recessive pattern. This means a child must receive one faulty copy of COX6A1 from each parent to develop the disease. Parents who carry one mutated copy are usually healthy but can pass the mutation to their children. EMBL-EBI+2Monarch Initiative+2

3. Homozygous COX6A1 mutations
   In many affected individuals, both copies of the COX6A1 gene have the same mutation (homozygous state). This complete loss of normal COX6A1 function in nerve cells strongly disrupts mitochondrial energy production and leads to early-onset neuropathy. MalaCards+2Monarch Initiative+2

4. Compound heterozygous COX6A1 mutations
   Some patients may carry two different harmful variants in COX6A1 (compound heterozygous). Each parent passes on a distinct faulty copy, and together they reduce functional protein below the level needed for healthy nerve function. MalaCards+2Monarch Initiative+2

5. Defective complex IV (cytochrome c oxidase) activity
   COX6A1 is part of complex IV, the last enzyme in the mitochondrial electron transport chain. When COX6A1 is abnormal, complex IV assembly or regulation is disturbed, and electrons cannot flow normally to oxygen. This lowers energy (ATP) production and stresses nerve cells. UniProt+2genecards.org+2

6. Reduced ATP supply in long peripheral nerves
   Peripheral nerves, especially those to the feet and hands, are very long and need large amounts of energy. In CMTRID, impaired complex IV function means less ATP is available, so axons and Schwann cells cannot maintain normal structure and signaling. Over time this energy shortage contributes to nerve fiber damage. UniProt+2Human Protein Atlas+2

7. Increased oxidative stress in nerve cells
   Mitochondrial dysfunction can increase reactive oxygen species (ROS). Excess ROS can damage lipids, proteins, and DNA inside nerve cells. In a person with COX6A1 mutations, this oxidative stress may further injure already fragile peripheral nerves. UniProt+2Human Protein Atlas+2

8. Secondary axonal degeneration
   When mitochondrial energy is insufficient, axons (the long extensions of nerve cells) cannot maintain their membranes and transport systems. Over time, this can cause axonal degeneration, which shows as reduced muscle strength and loss of sensation in the limbs. NCBI+2NCBI+2

9. Partial myelin dysfunction (intermediate pattern)
   Nerve conduction studies in CMTRID show speeds in the intermediate range, meaning both the axon and the myelin sheath are involved. Subtle myelin abnormalities related to COX6A1-driven energy problems may contribute to slower conduction without the very low speeds seen in classic demyelinating CMT. MalaCards+2UniProt+2

10. Childhood nervous system vulnerability
    Symptoms in CMTRID often start in childhood, when nerves and muscles are still developing. During this period, mitochondria must produce high amounts of energy to support growth. If COX6A1 is defective, this developmental window may be when nerve fibers first fail and weakness becomes visible. Genetic Diseases Info Center+2EMBL-EBI+2

11. Family history and carrier status
    Having parents, brothers, or sisters with CMT or known COX6A1 mutations increases the chance of CMTRID. In many families, several siblings are affected while parents are symptom-free carriers, which is typical for recessive diseases. EMBL-EBI+2MedlinePlus+2

12. Consanguinity (parents related by blood)
    In some reported families with recessive intermediate CMT, the parents are related (for example, cousins). When parents share recent ancestors, they are more likely to carry the same rare COX6A1 mutation, so their children have a higher chance of inheriting two faulty copies. EMBL-EBI+1

13. Modifier genes that change disease severity
    Researchers think that other genes may modify how severe CMT becomes, even when the main cause is COX6A1. These modifier genes might influence mitochondrial function, myelin health, or nerve repair, and they could explain why some people with the same mutation are milder or more severe. NCBI+2NCBI+2

14. General mitochondrial stressors
    Because the main defect is mitochondrial, any condition that further stresses mitochondria—such as certain toxins, severe infections, or poor overall health—might worsen symptoms in someone with CMTRID, even though these factors alone do not cause the disease. Doctors therefore try to avoid unnecessary mitochondrial-toxic drugs in people with inherited neuropathies. UniProt+2genecards.org+2

15. Age-related cumulative nerve damage
    CMTRID is slowly progressive. As years pass, ongoing energy shortage and oxidative stress lead to gradual additional damage to axons and myelin, so weakness and sensory loss slowly increase with age. NCBI+2NCBI+2

16. Mechanical stress on weak muscles and joints
    High-arched feet, weak ankle muscles, and poor balance can cause repeated small injuries to nerves, muscles, and joints. This does not start the disease but may accelerate muscle wasting and deformity once CMTRID is present. Muscular Dystrophy Association+2Life in the Fast Lane • LITFL+2

17. Poor posture and skeletal deformities
    Pes cavus, hammertoes, and possible spinal curvature change the way forces travel through the feet and spine. These skeletal changes often result from nerve weakness, but they can also feed back and increase strain on already compromised nerves and muscles. Muscular Dystrophy Association+2Orthobullets+2

18. Delayed diagnosis and lack of early support
    Because CMTRID is rare, diagnosis may be delayed. Without early physiotherapy, braces, or orthotic support, abnormal walking patterns may become fixed, and muscles may waste faster, making the disease appear worse over time. NCBI+2Orthobullets+2

19. Co-existing neuropathy from other causes
    Some people with genetic CMT can also develop other nerve problems, such as diabetic neuropathy or vitamin B12 deficiency. These additional conditions do not cause CMTRID but can add to nerve damage and make symptoms more severe. NCBI+2NCBI+2

20. Lifestyle factors that reduce overall nerve health
    Smoking, uncontrolled diabetes, severe malnutrition, and long-term alcohol misuse can all harm peripheral nerves. In a person who already has COX6A1-related neuropathy, these lifestyle factors may worsen weakness and numbness, although they are not the original cause of CMTRID. NCBI+2NCBI+2

Symptoms

Symptoms in CMTRID vary from person to person, but most people share a pattern of slowly progressive weakness and sensory loss starting in the feet and later involving the hands. NCBI+3Genetic Diseases Info Center+3EMBL-EBI+3

1. Unsteady gait (wobbly walking)
   Children with CMTRID often appear clumsy and may have trouble running or keeping up with peers. The weakness in the muscles that lift the foot causes tripping, and poor sensation in the feet makes it hard to feel the ground well. Genetic Diseases Info Center+2Genomics Education Programme+2

2. Frequent falls
   Because the ankle muscles are weak and balance is reduced, children and adults with CMTRID may fall more often than others. These falls usually happen when walking on uneven ground, in the dark, or when tired. Genetic Diseases Info Center+2NCBI+2

3. Pes cavus (high-arched feet)
   Many people develop high-arched, stiff feet with curled toes. This foot shape reflects an imbalance between weak muscles on the front of the leg and relatively stronger muscles on the back, a typical sign of CMT. Genetic Diseases Info Center+2Muscular Dystrophy Association+2

4. Foot drop
   Weakness of the muscles that lift the front of the foot leads to “foot drop.” The person may lift the knee high in a “steppage gait” to avoid dragging the toes, which can look unusual and tiring. Life in the Fast Lane • LITFL+3NCBI+3NCBI+3

5. Distal lower limb weakness and wasting
   Over time, muscles in the calves and feet become thin and wasted. The legs may look like an “inverted champagne bottle,” with narrower lower legs and relatively normal thighs. NCBI+2NCBI+2

6. Distal upper limb weakness
   As the disease progresses, weakness often spreads to the hands and forearms. People may have trouble with fine tasks such as buttoning clothes, writing, or opening jars. NCBI+2NCBI+2

7. Numbness in feet and hands
   CMTRID affects sensory fibers, so people commonly feel numbness or reduced ability to sense light touch. This is usually worse in the toes and fingertips and can make it harder to notice small injuries. Genetic Diseases Info Center+2Monarch Initiative+2

8. Tingling or “pins and needles”
   Some individuals describe tingling, buzzing, or burning feelings in the feet or hands. These unpleasant sensations arise from damaged sensory nerves sending mixed or abnormal signals. NCBI+2Muscular Dystrophy Association+2

9. Reduced or absent tendon reflexes
   Doctors often find that ankle reflexes are weak or absent when they tap the Achilles tendon. Knee reflexes may also be reduced. This loss of reflexes is a classic sign of peripheral neuropathy such as CMT. Genetic Diseases Info Center+2NCBI+2

10. Neuropathic pain
    Some people with CMTRID experience nerve-related pain, which can feel burning, stabbing, or electric-like. It may disturb sleep and make walking or standing more uncomfortable. Genetic Diseases Info Center+2NCBI+2

11. Bilateral sensorineural hearing loss
    In this subtype, a number of patients have been reported with hearing problems due to damage to the auditory nerve or inner ear structures. They may have difficulty hearing speech, especially in noisy places, and may need hearing aids. Genetic Diseases Info Center+2MalaCards+2

12. Fatigue and reduced stamina
    Weak muscles, poor nerve conduction, and increased effort during walking can all cause fatigue. People may feel tired after short distances and may need rest more often than their peers. NCBI+2Orthobullets+2

13. Balance problems, especially in the dark
    Because sensation from the feet is reduced, the brain receives less information about where the body is in space. Balance is particularly poor when vision is reduced, for example at night, leading to swaying or falls. NCBI+2Muscular Dystrophy Association+2

14. Hand deformities (later stages)
    If hand weakness progresses, some people develop clawing of fingers or difficulty extending the fingers fully. These changes are similar in concept to the pes cavus foot deformity but affect the small muscles of the hands. NCBI+2Life in the Fast Lane • LITFL+2

15. Slowly progressive course
    CMTRID usually progresses slowly over many years. Most children can walk independently for a long time, but may need orthoses, walking aids, or in severe cases a wheelchair later in adult life, depending on severity and support. Genetic Diseases Info Center+2NCBI+2

Diagnostic Tests

Doctors use a combination of history, examination, electrodiagnostic tests, imaging, and genetic analysis to diagnose CMTRID and distinguish it from other neuropathies. EMBL-EBI+3NCBI+3NCBI+3

Physical Examination Tests

1. Full neurological examination
   The doctor checks muscle strength, tone, reflexes, and sensation in all limbs. In CMTRID they often find weakness and wasting in the feet and hands, reduced ankle reflexes, and reduced vibration and pinprick sensation in a “stocking-and-glove” pattern. NCBI+2NCBI+2

2. Gait and posture assessment
   The patient is asked to walk normally, on heels, and on toes. In CMTRID, the doctor may see foot drop, a high-stepping gait, difficulty with heel-walking, and poor balance, which help point toward a length-dependent neuropathy like CMT. NCBI+2Orthobullets+2

3. Foot and spine inspection
   The clinician looks for pes cavus, hammertoes, and, in some cases, scoliosis (spinal curvature). These structural changes suggest a long-standing neuropathy and support the diagnosis of an inherited CMT form rather than a very recent nerve injury. Orthobullets+2Muscular Dystrophy Association+2

4. Cranial nerve and hearing check
   Because CMTRID can include hearing loss, the doctor tests hearing with simple bedside methods (whisper test, tuning fork) and checks other cranial nerves. Any abnormal findings guide referral for more detailed audiology tests. Genetic Diseases Info Center+2NCBI+2

Manual Bedside Tests

5. Manual muscle testing (MRC scale)
   The doctor grades each major muscle group on a 0–5 scale, comparing right and left sides. In CMTRID, distal muscles like ankle dorsiflexors and toe extensors are usually weaker than proximal muscles, which matches the typical CMT pattern. NCBI+2Orthobullets+2

6. Vibration sense with tuning fork
   A vibrating tuning fork is placed on the toes, ankles, and fingers. People with CMTRID often feel vibration poorly in the feet, showing large-fiber sensory nerve involvement, which is common in hereditary motor-sensory neuropathies. NCBI+2Muscular Dystrophy Association+2

7. Light touch and pinprick mapping
   Using a cotton wisp and a blunt pin, the doctor tests sensation in a systematic way up the legs and arms. In CMTRID, sensation is decreased distally, and this pattern helps differentiate length-dependent neuropathy from spinal cord or brain disorders. NCBI+2NCBI+2

8. Romberg test (balance with eyes closed)
   The patient stands with feet together, first with eyes open and then closed. Worsening swaying or falling when the eyes are closed suggests sensory ataxia due to loss of proprioceptive input from the feet, which is compatible with CMT-type neuropathies. NCBI+2Muscular Dystrophy Association+2

Laboratory and Pathological Tests

9. Routine blood tests to exclude acquired causes
   Tests such as glucose/HbA1c, vitamin B12, thyroid function, kidney and liver function, and sometimes folate, copper, or autoimmune markers are done to rule out common acquired neuropathies. In CMTRID, these are usually normal, supporting a hereditary cause. NCBI+2NCBI+2

10. Genetic testing for COX6A1 mutations
    The key confirmatory test is gene analysis. This can be a targeted COX6A1 test, an inherited neuropathy gene panel, or whole-exome/genome sequencing. Finding biallelic pathogenic variants in COX6A1 in a patient with typical clinical features confirms CMTRID. MalaCards+2Monarch Initiative+2

11. Extended neuropathy gene panel
    Because many genes can cause CMT, doctors often order a panel that checks dozens of neuropathy genes at once. This helps distinguish CMTRID from other intermediate CMT subtypes, such as those caused by GDAP1, KARS1, or PLEKHG5. MalaCards+2Charcot-Marie-Tooth Association+2

12. Nerve biopsy (rarely needed)
    In uncertain cases, a sural nerve biopsy may be performed. In hereditary neuropathies the biopsy can show loss of myelinated fibers and sometimes mixed axonal and demyelinating changes, but with modern genetic testing, biopsy is used less often. NCBI+2NCBI+2

Electrodiagnostic Tests

13. Nerve conduction studies (NCS)
    NCS measure the speed and size of electrical signals along motor and sensory nerves. In CMTRID, motor median nerve conduction velocities are typically in an intermediate range (around 25–45 m/s), and amplitudes may be reduced, reflecting both demyelination and axonal loss. MalaCards+2UniProt+2

14. Electromyography (EMG)
    EMG uses a needle electrode to record muscle electrical activity. In CMTRID, EMG often shows chronic denervation and re-innervation patterns in distal muscles, supporting a length-dependent peripheral neuropathy rather than a muscle disease. NCBI+2NCBI+2

15. F-wave studies
    F-waves are late responses that travel up and down the motor nerve. Prolonged or absent F-waves in CMTRID indicate involvement of the entire length of the motor nerve and support a diffuse neuropathic process. NCBI+1

16. Sensory nerve action potential (SNAP) testing
    Sensory nerve responses are often reduced or absent in the feet in CMTRID. Testing sural, superficial peroneal, and median sensory nerves helps quantify sensory involvement and can distinguish hereditary neuropathy from purely motor disorders. NCBI+2NCBI+2

Imaging Tests

17. X-rays of feet and ankles
    Standard X-rays show the structure of the bones and joints. In CMTRID, they may reveal high-arched feet, hammertoes, and other deformities that develop due to long-term muscle imbalance and neuropathy. Orthobullets+2Muscular Dystrophy Association+2

18. Spine X-rays
    If scoliosis or back pain is suspected, spinal X-rays can be done. These images help document any curvature or structural change that might need orthopedic assessment in addition to neurological care. Orthobullets+1

19. MRI of brainstem and inner ear pathways (in selected cases)
    When hearing loss is a major feature, MRI of the brainstem and internal auditory canals may be used to exclude other causes of sensorineural deafness. In CMTRID, MRI is often normal, but normal imaging supports the idea of a primary neuropathic, genetic cause. Genetic Diseases Info Center+2NCBI+2

20. Ultrasound or MRI of peripheral nerves (research or specialized centers)
    High-resolution ultrasound or MRI can sometimes show nerve enlargement or structural changes in peripheral nerves. These techniques are used mainly in research or specialized clinics to better understand CMT anatomy, and they may help distinguish hereditary neuropathies from inflammatory ones. NCBI+2Wiley Online Library+2

Non-pharmacological treatments (therapies and other approaches)

Below are key non-drug treatments often used in CMT. Not every person needs all of them; your neurologist and therapists choose what fits your situation.

1. Regular physiotherapy and stretching
   Physiotherapy is one of the most important treatments in CMT. A physiotherapist teaches safe stretching and low-impact strengthening exercises to keep joints flexible and muscles as strong as possible. This helps slow down contractures (tight, fixed joints) and can reduce pain and stiffness. Simple home programmes may include ankle and calf stretches, core stability, gentle cycling, or swimming. Doing exercises consistently, but not to the point of exhaustion, is key to long-term benefit.Journal of Health and Allied Sciences NU+4nhs.uk+4Physiopedia+4

2. Strength and endurance training
   Supervised strength and endurance training focuses on muscles that are less affected, such as hips and thighs, and on overall fitness. Light resistance bands, water aerobics, or walking programmes can improve daily function and reduce fatigue. In CMT, training must be gentle and long-term, not “no-pain, no-gain”, because overworking very weak muscles can backfire. When done correctly, studies show that strengthening and endurance exercises improve mobility and ability to perform daily activities.Journal of Health and Allied Sciences NU+3PMC+3The Physio Lab+3

3. Balance and gait (walking) training
   Weakness in feet and lower legs plus loss of sensation makes balance difficult and increases fall risk. Physiotherapists design balance exercises (for example: standing with feet together, heel-to-toe walking, or using balance boards) and gait training with or without assistive devices. These programmes aim to improve posture, step length, and safety during walking. Over time, better balance can lower fear of falling and help people stay more active and independent.The Physio Lab+2Journal of Health and Allied Sciences NU+2

4. Ankle-foot orthoses (AFOs) and other braces
   Many people with CMT develop “foot drop”, where the toes drag during walking. Ankle-foot orthoses (AFOs) or lighter carbon-fibre braces hold the ankle in a better position and help clear the toes. This can reduce falls, fatigue, and joint strain. Bracing can also help control high-arched or unstable feet. The orthotist and therapist must check for pressure points because numb feet can be injured by rubbing.Muscular Dystrophy Association+3Pod NMD+3Charcot-Marie-Tooth Association+3

5. Custom footwear and foot orthoses
   Custom shoes and in-shoe orthotic inserts spread pressure more evenly, support the arch, and correct some misalignment. This can reduce pain in the sole, improve foot function, and delay worsening of deformity, especially in people with pes cavus (high-arched foot). Soft, wide shoes with good ankle support and non-slip soles are usually recommended.Pod NMD+2ScienceDirect+2

6. Occupational therapy and hand therapy
   Occupational therapists focus on daily activities such as dressing, writing, using a phone, or cooking. They may provide hand exercises, splints, and adaptive tools (for example, built-up pens, zipper pulls, or special cutlery) to improve function when hand weakness or numbness appears. They can also suggest job and school adaptations so that people can continue education or work with less fatigue and strain.Physiopedia+2PMC+2

7. Podiatry and skin care
   Because feeling in the feet is reduced, small injuries can go unnoticed and become ulcers. Regular podiatry care for nails, calluses, and pressure areas is important, especially in people with deformities. Patients are taught to check their feet daily, keep skin moisturized but dry between toes, and avoid walking barefoot. Quick treatment of blisters or cuts helps prevent infection.Pod NMD+2Muscular Dystrophy Association+2

8. Pain psychology, cognitive-behavioural therapy (CBT), and relaxation
   Neuropathic pain and chronic disability can affect mood and sleep. Psychological therapies such as CBT, mindfulness, or relaxation training help people manage pain signals, reduce anxiety and depression, and improve coping skills. These approaches do not stop nerve damage but can make pain feel more controllable and reduce the emotional burden of a lifelong condition.Charcot-Marie-Tooth Association+2American Academy of Neurology+2

9. Sleep hygiene and fatigue management
   Many people with CMT report poor sleep because of pain, cramps, or restless legs, which then worsens daytime fatigue. Sleep hygiene (regular sleep schedule, limiting screens before bed, comfortable positioning, and sometimes supportive pillows or splints) plus pacing of daytime activities can improve energy levels. Therapists may teach energy-saving techniques, such as planning rest breaks and spreading heavy tasks through the week.Charcot-Marie-Tooth Association+1

10. Fall-prevention education and home modifications
    Falls are common due to foot drop, balance problems, and numbness. Occupational therapists may advise grab bars, non-slip mats, good lighting, and removing loose rugs or clutter. They may also recommend canes, walking sticks, or walkers for extra stability. The aim is to create a safer home and school or work environment so that minor trips do not turn into major injuries.The Physio Lab+2MDPI+2

11. Genetic counselling and family planning support
    Because recessive intermediate CMT-D is inherited, genetic counsellors help families understand carrier status, recurrence risk in future pregnancies, and options such as prenatal or pre-implantation testing. This does not change the disease in the person who already has it, but it helps families make informed decisions and reduces anxiety about “passing it on”.Genetic Diseases Info Center+2Monarch Initiative+2

12. Support groups and patient organizations
    Patient organizations and online or local support groups provide education, emotional support, and practical tips from people living with CMT. They also connect families with information on research studies and clinical trials. Feeling understood and less alone can strongly improve mental health and quality of life.Charcot-Marie-Tooth Disease+3CMT Research Foundation+3Charcot-Marie-Tooth Disease+3

---

Drug treatments for symptoms

Very important: no medicine is currently approved to cure or directly stop Charcot-Marie-Tooth disease. Medicines are used mainly to treat neuropathic pain, cramps, mood problems, and associated conditions. All drug use must be guided by a neurologist or pain specialist; doses below are general label-based ranges for adults, not personal advice.www.elsevier.com+3Physiopedia+3PMC+3

1. Gabapentin (Neurontin, Gralise, Horizant)
   Gabapentin is an anticonvulsant widely used for neuropathic pain. It binds to α2δ subunits of voltage-gated calcium channels in nerves and reduces abnormal pain signalling. Typical adult doses for neuropathic pain range from 900–3,600 mg per day in divided doses, increased slowly to balance pain relief and side effects such as sleepiness or dizziness. It is approved by the FDA for post-herpetic neuralgia, and its use in CMT pain is off-label but supported by general neuropathic pain guidelines.وزارة الصحة السعودية+4FDA Access Data+4FDA Access Data+4

2. Pregabalin (Lyrica, Lyrica CR)
   Pregabalin is closely related to gabapentin and also targets α2δ calcium channel subunits. It is FDA-approved for neuropathic pain due to diabetes, post-herpetic neuralgia, spinal cord injury, fibromyalgia, and as an add-on treatment for partial seizures. Typical adult starting doses are about 150 mg per day in 2–3 divided doses, which may be titrated up (for example to 300–450 mg/day) based on response and kidney function. Common side effects include dizziness, weight gain, and swelling. In CMT, it is used off-label to reduce burning, shooting nerve pain and sometimes improve sleep.ScienceDirect+5FDA Access Data+5FDA Access Data+5

3. Duloxetine (Cymbalta, Drizalma Sprinkle)
   Duloxetine is a serotonin–noradrenaline re-uptake inhibitor (SNRI) antidepressant. It is FDA-approved for diabetic neuropathic pain, fibromyalgia, chronic musculoskeletal pain, and several mood and anxiety disorders. Typical adult neuropathic pain doses are around 60 mg once daily, sometimes up to 120 mg/day. It works by enhancing descending pain-inhibiting pathways in the brain. Side effects can include nausea, dry mouth, sweating, and, rarely, liver problems, so doctors monitor liver history and drug interactions. In CMT with neuropathic pain and low mood, duloxetine can help both pain and depression.Pain Data+5FDA Access Data+5FDA Access Data+5

4. Amitriptyline (tricyclic antidepressant)
   Amitriptyline is one of the oldest drugs used for neuropathic pain. At low doses (for example 10–25 mg at night, sometimes increased cautiously), it can reduce burning and electric-shock-like pain and improve sleep. It blocks reuptake of serotonin and noradrenaline and also affects sodium channels and other receptors involved in pain signalling. Side effects may include dry mouth, constipation, drowsiness, weight gain, and, at higher doses, heart rhythm problems, so careful monitoring is needed. Evidence quality is mixed, but it remains a standard first-line option in many neuropathic pain guidelines.Pain Data+5PMC+5Cochrane+5

5. Nortriptyline or other tricyclic antidepressants
   Nortriptyline, a related tricyclic with slightly fewer sedating and anticholinergic effects than amitriptyline, is sometimes used when amitriptyline causes too many side effects. Dosing again starts low at night and is increased gradually. The mechanism is similar: boosting pain-inhibiting neurotransmitters and modulating ion channels. This class is recommended as first-line or early second-line in many neuropathic pain algorithms.PMC+2Northern Lincolnshire APC+2

6. Venlafaxine and other SNRIs
   Venlafaxine is another SNRI that can help neuropathic pain and depression, especially when duloxetine is not tolerated. It increases serotonin and noradrenaline levels and may dampen pain pathways in the central nervous system. Doses and schedules vary, and blood pressure must be monitored. Evidence in neuropathic pain is moderate, and use in CMT is extrapolated from other causes of nerve pain.PMC+2وزارة الصحة السعودية+2

7. Topical lidocaine 5% patches
   Lidocaine skin patches give local numbing to painful areas, such as a very sensitive part of the foot. They block sodium channels in peripheral nerve endings and reduce spontaneous pain firing. Up to three patches can be applied to intact skin for up to 12 hours in 24 hours in adults, according to label instructions. They are especially useful when pain is focal and systemic drugs cause too many side effects.وزارة الصحة السعودية+2Pain Data+2

8. Capsaicin 8% patch or lower-strength creams
   High-concentration capsaicin patches, applied in a clinic, temporarily “defunctionalize” superficial pain fibres by overwhelming TRPV1 receptors. This can reduce neuropathic pain for weeks to months in some patients, though application is briefly painful and needs medical supervision. Lower-dose capsaicin creams are available over the counter but are usually less effective. The role of capsaicin in CMT-related pain is not fully studied but may help in selected cases.ScienceDirect+2Pain Data+2

9. Baclofen (oral)
   Baclofen is a muscle relaxant that acts as a GABA-B receptor agonist. It is FDA-approved for spasticity, particularly in multiple sclerosis and spinal cord disease, but in CMT it may be used off-label in low doses to reduce painful muscle spasms, cramps, or rigidity if these are prominent. Typical adult starting doses are 5–10 mg three times daily, adjusted carefully to avoid excessive weakness, dizziness, or sedation. Abrupt withdrawal can be dangerous, so it must never be stopped suddenly.FDA Access Data+3FDA Access Data+3FDA Access Data+3

10. Short-term use of tramadol or other weak opioids (with caution)
    Some people have severe pain not relieved by first-line neuropathic pain medicines. In such situations, tramadol (a weak opioid with additional SNRI action) may be prescribed for short periods. It acts on opioid receptors and monoamine pathways to reduce pain. Side effects include nausea, constipation, drowsiness, and risk of dependence or withdrawal, so guidelines recommend reserving it for second- or third-line use and avoiding long-term daily dosing whenever possible.Charcot-Marie-Tooth Association+3PMC+3وزارة الصحة السعودية+3

Other drugs like topiramate, carbamazepine, tizanidine, or botulinum toxin injections may be considered in special situations by specialists, but evidence in CMT is limited and they are not routine first-line options.American Academy of Neurology+3PMC+3ScienceDirect+3

---

Dietary molecular supplements

Supplements are not a cure and evidence in CMT itself is limited. Some have data in other peripheral neuropathies, mainly diabetic or chemotherapy-induced neuropathy. Always discuss supplements with a doctor, especially if you already take medicines.

1. Alpha-lipoic acid (ALA)
   Alpha-lipoic acid is an antioxidant that helps mitochondria handle oxidative stress. In diabetic neuropathy, oral ALA (for example 600–1,800 mg/day in studies) has shown modest improvements in pain and nerve function in some trials, though results are mixed. It may theoretically protect nerves from further damage, but its role in CMT is unproven, so it is considered an experimental adjunct, not standard treatment.Cochrane Library+4MDPI+4PubMed+4

2. Acetyl-L-carnitine (ALC)
   Acetyl-L-carnitine participates in energy transport into mitochondria and may support nerve regeneration. Meta-analyses in peripheral neuropathy suggest that doses around 1–3 g/day can moderately reduce pain and may improve nerve conduction, with a generally good safety profile. Again, there are no high-quality trials in CMT, but some clinicians consider it as an add-on after discussing uncertain benefits, costs, and potential gastrointestinal side effects.ASCOPubs+4PMC+4PLOS+4

3. Vitamin B12 (cobalamin)
   Vitamin B12 is essential for myelin production and healthy nerve function. B12 deficiency itself can cause neuropathy, so doctors often check B12 levels in anyone with nerve problems. If B12 is low, replacement with tablets or injections (dose depends on deficiency severity and absorption) can improve symptoms and prevent permanent damage. In CMT, correcting B12 deficiency is vital because adding a second neuropathy would make disability worse. Supplements are usually only helpful if there is true deficiency or increased risk.The Times of India+6Cleveland Clinic+6PubMed+6

4. Omega-3 fatty acids (fish oil, EPA/DHA)
   Omega-3 fatty acids help maintain cell membranes and may support nerve repair. Animal studies and some human data suggest they can promote nerve regeneration and reduce neuropathic pain behaviour, though large clinical trials in diabetic neuropathy show mixed results. Typical supplement doses vary (for example 1–3 g/day of combined EPA/DHA), but high doses can increase bleeding risk and interact with some medicines. In CMT, omega-3s may be reasonable for general health (heart, brain) but are not proven as a specific treatment.Queen Mary University of London+4PMC+4Frontiers+4

5. Vitamin D
   Vitamin D is important for bone health, muscle function, and immune regulation. Low vitamin D is common in people with limited mobility or low outdoor activity. Correcting deficiency (dose depends on blood level and local guidelines) may improve muscle function and reduce fracture risk, which is important in people at high risk of falls. Its direct effect on neuropathy is less clear, but maintaining normal levels is part of general health care in chronic neurological diseases.Muscular Dystrophy Association+2PMC+2

6. Coenzyme Q10 and other antioxidants
   Coenzyme Q10 works in mitochondrial energy production and has antioxidant properties. Some small studies in other neuromuscular conditions suggest possible benefits for fatigue and muscle function, but strong evidence is lacking. In CMT, these supplements are sometimes tried on an individual basis after discussion of uncertain benefit and financial cost. They should not replace proven therapies like physiotherapy and orthotic use.Exploration Publishing+3PMC+3AFM Téléthon+3

---

Regenerative and immune-modulating approaches

Right now, there are no approved stem-cell or gene therapies for recessive intermediate CMT-D, and no immune “booster” drug has been shown to reverse the disease. However, research is moving quickly.CMT Research Foundation+4PMC+4PMC+4

Researchers are testing different gene-therapy strategies in some CMT subtypes, aiming to add a healthy copy of the gene, silence a toxic gene, or correct the mutation. Early-phase clinical trials exist for some types, and plasmid-based and AAV-based gene therapies are being studied, but these are experimental and not available as routine care. Doses, schedules, and long-term safety are still being worked out in carefully controlled trials.AFM Téléthon+4PMC+4Charcot-Marie-Tooth Disease+4

Stem-cell approaches (for example, using mesenchymal stem cells or neural stem cells) are also being researched in animal models of peripheral nerve disease, but no stem-cell drug is approved for CMT. Any clinic offering “stem-cell cures” outside regulated clinical trials should be viewed with extreme caution. Always check that any such treatment is part of a registered trial with ethics approval.AFM Téléthon+3PMC+3PMC+3

Because CMT is not primarily an autoimmune disease, typical immune-suppressing medicines (like steroids or IVIG) used in acquired neuropathies are not standard for recessive intermediate CMT-D and can even be harmful if used without a clear indication.PMC+2www.elsevier.com+2

---

Surgical treatments

Surgery does not fix the nerve damage but can correct deformities, improve the foot’s shape, and make walking and shoe fitting easier. Decision for surgery is always individual and taken by an experienced orthopaedic or neuromuscular surgeon.PMC+4nhs.uk+4Muscular Dystrophy Association+4

1. Foot deformity correction (osteotomies, joint releases)
   In severe pes cavus or claw toes, the surgeon may cut and realign bones (osteotomies), release tight soft tissues, and sometimes fuse joints to create a more plantigrade foot. This can make bracing and shoes more effective and reduce pain and calluses. Recovery involves a period in casts or boots plus physiotherapy.

2. Tendon transfers
   Tendon transfer surgery takes a working tendon and reattaches it to help a weak function, for example to improve foot dorsiflexion and reduce foot drop. The goal is a more balanced foot with less tripping. Surgery is usually done when muscles are weak but not totally wasted and when bracing alone is not enough.

3. Ankle or hindfoot fusion (arthrodesis)
   In very unstable or painful joints, especially in older patients, fusion of ankle or hindfoot joints may be considered. Fusing the joint sacrifices movement but can give a more stable, pain-free platform for standing and walking, often with braces or special shoes.

4. Hand and wrist surgery
   In some people with severe hand deformities or tendon imbalance, surgery to release tight tendons or stabilize joints can improve pinch and grip. Postoperative hand therapy is essential to train the new movement patterns.

5. Spine surgery (for scoliosis)
   A minority of people with CMT develop scoliosis (spine curvature). If the curve is severe and progressing, spinal fusion may be considered to prevent worsening, improve sitting balance, and reduce pain. This is less common than foot surgery but can be important in selected patients.MDPI+3Muscular Dystrophy Association+3Mayo Clinic+3

---

Prevention and everyday care

You cannot prevent the genetic mutation, but you can reduce avoidable damage and complications:

1. Protect feet every day: check skin, avoid walking barefoot, and treat blisters or cuts early.Pod NMD+1

2. Use braces, orthoses, and shoes as prescribed to reduce falls and joint stress.Charcot-Marie-Tooth Association+2Pod NMD+2

3. Keep up regular physiotherapy to maintain strength and joint range; stopping completely often leads to stiffness and loss of function.PMC+2MDPI+2

4. Avoid known neurotoxic drugs (for example some chemotherapy agents, high-dose metronidazole) whenever safer alternatives exist; your neurologist can review medicines.www.elsevier.com+2وزارة الصحة السعودية+2

5. Do not smoke, and limit alcohol, as both can worsen nerve damage.www.elsevier.com+1

6. Manage weight with healthy diet and activity to reduce strain on weak legs and feet.Muscular Dystrophy Association+1

7. Keep vaccinations up to date (for example, flu, pneumonia) to reduce serious illness that could result in long inactivity or hospitalization.Muscular Dystrophy Association+1

8. Stay informed about CMT clinical trials and research through trusted organizations; new options may appear over time.NeurologyLive+3CMT Research Foundation+3PMC+3

---

When to see doctors

You should be under regular care of a neurologist experienced in neuromuscular diseases, plus therapists and an orthotist. See or contact a doctor urgently if:

• You notice a sudden or rapid worsening of weakness, sensation loss, or balance (for example, going from walking to not walking over weeks rather than years). This may suggest another treatable problem on top of CMT.Mayo Clinic+1

• Pain becomes severe, constant, or is not controlled by your usual plan.Mayo Clinic+2American Academy of Neurology+2

• You develop new bowel or bladder problems, severe back pain, or loss of feeling in the groin area, which are not typical for CMT and need urgent evaluation.Mayo Clinic+1

• You see skin breakdown, ulcers, or infection on your feet or legs, especially if you have poor sensation.Pod NMD+1

• You have repeated falls, head injuries, or fractures.The Physio Lab+1

Regular scheduled visits (for example yearly, or more often in childhood or during fast changes) are used to monitor progression, adjust braces and therapies, and screen for mood, sleep, nutrition, and bone health.PMC+2Muscular Dystrophy Association+2

---

What to eat and what to avoid

There is no special “CMT diet”, but general nerve- and muscle-friendly nutrition helps overall health:

1. Eat a balanced diet rich in whole grains, fruits, vegetables, lean proteins, and healthy fats (like olive oil and fish). This supports energy and weight control.Muscular Dystrophy Association+2PMC+2

2. Eat foods carrying B-vitamins (especially B12 if you are not vegetarian or vegan) such as meat, fish, eggs, and dairy, or use fortified foods if you do not eat animal products.The Times of India+3Cleveland Clinic+3nhs.uk+3

3. Eat sources of omega-3 fatty acids like fatty fish (salmon, mackerel, sardines), walnuts, and flaxseed, which support general cardiovascular and possibly nerve health.ScienceDirect+3PMC+3Frontiers+3

4. Eat enough calcium and vitamin D from dairy, fortified plant milks, and safe sun exposure to support bones.nhs.uk+2Muscular Dystrophy Association+2

5. Avoid heavy drinking and binge alcohol use, which can directly damage nerves and worsen balance and falls.www.elsevier.com+1

6. Avoid crash diets and extreme weight loss plans; they can cause nutrient deficiencies and muscle loss, making weakness worse.nhs.uk+1

7. Avoid high-sugar ultra-processed foods in large amounts; they promote weight gain and may increase risk of diabetes, which itself causes neuropathy.nhs.uk+2Cleveland Clinic+2

8. Be cautious with supplements bought online that claim to “cure CMT” or “regrow nerves”. Many have no scientific proof and can interact with medicines. Always discuss supplements with your doctor first.Cochrane+3PMC+3AFM Téléthon+3

9. Stay hydrated, especially if you take medicines that cause dizziness or low blood pressure; dehydration can worsen falls.وزارة الصحة السعودية+2Pain Data+2

10. If you have another condition (such as diabetes, high blood pressure, or kidney disease), follow the diet planned for that condition as well; uncontrolled medical problems can add more nerve damage or fatigue on top of CMT.nhs.uk+2وزارة الصحة السعودية+2

---

Frequently asked questions (FAQs)

1. Is Charcot-Marie-Tooth disease recessive intermediate D fatal?
   Most people with CMT, including recessive intermediate forms, have a normal life span. The disease mainly affects movement and sensation rather than vital organs. Serious problems usually come from falls, severe deformities, or other unrelated illnesses, which is why prevention and regular care are important.Genetic Diseases Info Center+2Mayo Clinic+2

2. Can exercise make the disease worse?
   Correctly prescribed, low-to-moderate intensity exercise is helpful and does not speed up nerve damage. Over-training very weak muscles, however, may cause fatigue or strain. Physiotherapists experienced in neuromuscular disease design safe programmes that focus on strong or partly strong muscles, balance training, and flexibility, rather than heavy weights.MDPI+3PMC+3The Physio Lab+3

3. Why do I need braces if I can still walk?
   Braces such as AFOs can save energy, improve foot positioning, reduce tripping, and protect joints. Using them early can sometimes delay worsening deformity and keep you independent for longer. They are not a sign that “you are giving up”, but a tool to help you keep moving more safely.Charcot-Marie-Tooth Association+2Pod NMD+2

4. Will any medicine stop progression of CMT?
   At present, no medicine has been proven to halt or reverse CMT progression. All current drugs focus on symptoms such as pain, cramps, or mood. Research into disease-modifying medicines and gene therapy is active, and clinical trials are ongoing for some subtypes, but nothing is yet standard for recessive intermediate D.AFM Téléthon+4Physiopedia+4PMC+4

5. Is pain a normal part of Charcot-Marie-Tooth disease?
   Neuropathic pain is common in CMT, although not everyone has it. When present, it may feel like burning, electric shocks, stabbing, or deep aching. Pain can come from both nerve damage and joint or muscle problems. It should always be discussed with your doctor; many treatments (medicines, physiotherapy, psychological therapies) can reduce its impact.Charcot-Marie-Tooth Association+3American Academy of Neurology+3Wiley Online Library+3

6. Are children treated differently from adults?
   Children and teenagers need special attention to growth, school participation, and emotional wellbeing. Therapies aim to support normal development, play, and schooling, with braces, physiotherapy, and early surgery if deformities are severe. Medicine doses are carefully adjusted to age and weight, and doctors avoid drugs that might affect growth or learning.Genetic Diseases Info Center+2Muscular Dystrophy Association+2

7. Should I have genetic testing?
   Genetic testing can confirm the specific subtype and help with prognosis, family planning, and access to research trials. However, it does not yet change standard treatment in most cases. A neurologist and genetic counsellor can help decide whether testing is right for you and explain what the results would mean.www.elsevier.com+3Genetic Diseases Info Center+3Monarch Initiative+3

8. Can pregnancy or hormones worsen CMT?
   Many people with CMT go through pregnancy without major changes, but some notice temporary increases in weakness or fatigue due to weight gain, balance changes, and hormonal effects on ligaments. Obstetric and neurology teams can plan safe delivery, and physiotherapy can help with back and pelvic support.PMC+1

9. Are there medicines I must avoid?
   Some medicines are known or suspected to worsen neuropathy (for example certain chemotherapy drugs, high-dose metronidazole, and others). People with CMT should always tell any doctor or dentist about their diagnosis so that drug choices can be checked against neuropathy-risk lists.www.elsevier.com+2وزارة الصحة السعودية+2

10. Can diet alone treat CMT?
    No diet can fix the genetic cause of CMT. However, good nutrition supports muscle and bone health, weight control, and overall energy, which all make living with CMT easier. Diet can also treat or prevent other problems (like B12 deficiency or diabetes) that would otherwise add more nerve damage on top of CMT.Muscular Dystrophy Association+3Cleveland Clinic+3PubMed+3

11. Is CMT the same as muscular dystrophy?
    No. CMT is a neuropathy, meaning the problem is mainly in the peripheral nerves, while muscular dystrophies are primary muscle diseases. Both can cause weakness and wasting, but their causes, patterns, and treatments are different.Genetic Diseases Info Center+2PMC+2

12. Can I play sports if I have CMT?
    Many people with mild to moderate CMT can safely participate in low-impact sports such as swimming, cycling, or walking. Contact sports and high-impact activities (like jumping from heights or running on uneven ground) may increase risk of injury or falls. A physiotherapist can help choose and adapt activities that match your abilities.The Physio Lab+2MDPI+2

13. Will I need a wheelchair?
    Some people with more severe CMT eventually use a wheelchair part-time or full-time, especially for long distances. This does not mean therapy has failed; sometimes using wheels actually increases independence by saving energy and preventing falls, while you continue to walk short distances with aids.PMC+2Muscular Dystrophy Association+2

14. How often should I have follow-up appointments?
    Follow-up frequency depends on age, severity, and whether symptoms are changing. Children and people with rapid changes may be seen every 3–6 months. Adults with stable disease may be reviewed yearly, with extra visits when new problems appear. Ongoing review ensures braces still fit, exercises are updated, and pain or mood problems are addressed early.PMC+2Muscular Dystrophy Association+2

15. What is the most important thing I can do right now?
    The single most powerful step is to build a long-term partnership with your care team: attend regular neurology and therapy visits, use braces and aids consistently, keep active within safe limits, protect your feet, and talk openly about pain and mood. Small daily actions add up over many years to preserve independence and quality of life with Charcot-Marie-Tooth disease recessive intermediate D.Charcot-Marie-Tooth Disease+3PMC+3Muscular Dystrophy Association+3

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: December 24, 2025.